TG-100948

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTG-100948
Drug Alias NameTG-100948TG-101209TG-101095
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRC
Therapy Area/IndicationsDiabetic macular oedemaMyeloproliferative DisordersChoroidal Neovascularization +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaMyeloproliferative DisordersChoroidal Neovascularization +[4] 

Other Information

ATC CodeN/A
Related LinksN/A